Transcriptional profile of isoproterenol-induced cardiomyopathy and comparison to exercise-induced cardiac hypertrophy and human cardiac failure
about
RING finger protein RNF207, a novel regulator of cardiac excitationCpG-ODN attenuates pathological cardiac hypertrophy and heart failure by activation of PI3Kα-Akt signalingRare Copy Number Variants Identified Suggest the Regulating Pathways in Hypertension-Related Left Ventricular HypertrophyPhosphorylation of the ryanodine receptor mediates the cardiac fight or flight response in mice.GeneTopics--interpretation of gene sets via literature-driven topic modelsβ-adrenergic receptor-dependent alterations in murine cardiac transcript expression are differentially regulated by gefitinib in vivoThe impact of juvenile coxsackievirus infection on cardiac progenitor cells and postnatal heart developmentDifferential and conditional activation of PKC-isoforms dictates cardiac adaptation during physiological to pathological hypertrophy.Remodeling of the heart in hypertrophy in animal models with myosin essential light chain mutations.Deep RNA sequencing reveals novel cardiac transcriptomic signatures for physiological and pathological hypertrophyDistinct cardiac transcriptional profiles defining pregnancy and exerciseAnimal models of cardiac disease and stem cell therapy.Energy metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach.Assessing the translatability of in vivo cardiotoxicity mechanisms to in vitro models using causal reasoning.Temporal and gefitinib-sensitive regulation of cardiac cytokine expression via chronic β-adrenergic receptor stimulation.Sirtuins, aging, and cardiovascular risks.Panhistone deacetylase inhibitors inhibit proinflammatory signaling pathways to ameliorate interleukin-18-induced cardiac hypertrophy.Genetic Dissection of Cardiac Remodeling in an Isoproterenol-Induced Heart Failure Mouse Model.Imatinib attenuates cardiac fibrosis by inhibiting platelet-derived growth factor receptors activation in isoproterenol induced model.Dual specificity phosphatase 4 mediates cardiomyopathy caused by lamin A/C (LMNA) gene mutationEndurance training in early life results in long-term programming of heart mass in ratsPilot study identifying myosin heavy chain 7, desmin, insulin-like growth factor 7, and annexin A2 as circulating biomarkers of human heart failureLoss of Mouse P2Y6 Nucleotide Receptor Is Associated with Physiological Macrocardia and Amplified Pathological Cardiac Hypertrophy.β-Adrenergic receptor antagonism in mice: a model for pediatric heart disease.Novel Sulfur Metabolites of Garlic Attenuate Cardiac Hypertrophy and Remodeling through Induction of Na+/K+-ATPase Expression.Genetic background influences adaptation to cardiac hypertrophy and Ca(2+) handling gene expression.Aromatic Amines Exert Contrasting Effects on the Anticoagulant Effect of Acetaldehyde upon APTT.A systems genetics approach identifies Trp53inp2 as a link between cardiomyocyte glucose utilization and hypertrophic response.Heterozygous deletion of sarcolipin maintains normal cardiac function.Integrated omics dissection of proteome dynamics during cardiac remodeling.Identification of potentially relevant genes for myocardial infarction using RNA sequencing data analysis.Understanding Key Mechanisms of Exercise-Induced Cardiac Protection to Mitigate Disease: Current Knowledge and Emerging Concepts.Causal reasoning on biological networks: interpreting transcriptional changes.Carnosic acid promotes myocardial antioxidant response and prevents isoproterenol-induced myocardial oxidative stress and apoptosis in mice.Comparative phenotypic assessment of cardiac pathology, physiology, and gene expression in C3H/HeJ, C57BL/6J, and B6C3F1/J mice.Bioinformatic screening for key miRNAs and genes associated with myocardial infarction.Systems Genetics Approach to Biomarker Discovery: GPNMB and Heart Failure in Mice and Humans
P2860
Q24305127-27718891-44D6-4A33-85E2-D6C78D335473Q28487365-FA7D152F-8104-4990-80A1-5E009BD6FD38Q28603500-43770B26-F79E-419D-B358-12968FA3FCE6Q30497498-3830F23A-E10C-4ED3-AB3E-01B9E3D28DA7Q33642727-C0E9C219-2E4E-4E0B-8035-06783D8CE54FQ33717215-C4263C2F-E1B8-4F1D-8727-2DB8734979EEQ33982587-EDE4EEE1-E73C-45C8-BE57-3A6851F12FE4Q34035413-565849F0-0E54-4F81-B955-5D55868084A9Q34219487-97A2F2B6-4A12-4D6D-AF6F-29BC95A9274BQ34241891-3AEC323F-C420-484E-BFE9-67852647F55AQ34364776-0DF064C2-415A-4462-B504-3E3AFF92D72EQ34508351-DB57CB0C-6B83-440F-8671-947717216C83Q34559786-0A09325B-7D2F-4093-B133-79528BA831CFQ34980120-FF74BFBB-16DC-4534-94DD-51E03D6FE005Q35086445-6367C3E5-AC8B-43A4-9783-20201E46958BQ35768345-7A161E41-23F9-4A9B-B04E-1F30F309A445Q35813603-6DA4B306-2F72-4FBC-9FF5-609D2654E6C8Q36069291-C5267675-2F7F-4FFC-A176-7146025E05FEQ36389384-379549F8-CEE5-4B79-83EE-51D5ADFE188CQ36418867-021CA3F4-353A-47E1-9CA6-84611B7EFFAFQ36594412-15486F3E-B622-4B56-8A30-209624CA4FDCQ37075424-421EA657-7C56-4B68-A014-C7DBFFDCECCFQ37117338-B1290D7B-3A25-4273-B651-276476510A5BQ37235097-845A39D0-3BE1-422C-8D96-0ADA0CDAF06FQ38963183-3D5A5CE4-B74B-4328-A7C4-1FC227BA207DQ41546678-AE3556BB-2934-4A42-8DE2-3F5932E21CDAQ43077613-6C44F679-9B99-4E04-8C9E-9E414BFFB880Q44234183-D58C810C-4979-46FF-B1B7-6D242FC16F13Q46421083-206D2398-7CB9-47C5-BA31-3C1BA68796EFQ47215682-6E7CE324-66A4-4589-A4FA-AEA746D51ABCQ49335362-10D7E36B-F81E-4B87-8E54-65B14BE15C7FQ49917356-518327DC-E0D6-4073-BF51-4759C1FA0E89Q51418637-569D217E-40AC-42F4-B442-70794ADDE725Q53044367-6B8AC25B-9583-42F2-84ED-BAFC1424E245Q53452720-60E8F989-5F01-4F1D-A757-F77778E1B0AFQ55383851-AF8F5039-A9EE-402F-84E2-562D5593028CQ58752679-0D9C2E27-B4FB-424F-9248-61E5F5F5C3B7
P2860
Transcriptional profile of isoproterenol-induced cardiomyopathy and comparison to exercise-induced cardiac hypertrophy and human cardiac failure
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Transcriptional profile of iso ...... ophy and human cardiac failure
@ast
Transcriptional profile of iso ...... ophy and human cardiac failure
@en
Transcriptional profile of iso ...... ophy and human cardiac failure
@en-gb
Transcriptional profile of iso ...... ophy and human cardiac failure
@nl
type
label
Transcriptional profile of iso ...... ophy and human cardiac failure
@ast
Transcriptional profile of iso ...... ophy and human cardiac failure
@en
Transcriptional profile of iso ...... ophy and human cardiac failure
@en-gb
Transcriptional profile of iso ...... ophy and human cardiac failure
@nl
prefLabel
Transcriptional profile of iso ...... ophy and human cardiac failure
@ast
Transcriptional profile of iso ...... ophy and human cardiac failure
@en
Transcriptional profile of iso ...... ophy and human cardiac failure
@en-gb
Transcriptional profile of iso ...... ophy and human cardiac failure
@nl
P2093
P2860
P3181
P356
P1433
P1476
Transcriptional profile of iso ...... ophy and human cardiac failure
@en
P2093
Cristi L Galindo
David A Watson
Harold R Garner
John F McCormick
L Danielle Olson
Lauren J McIver
Michael A Skinner
Mounir Errami
Neil M Kumar
Thinh Q Pham
P2860
P2888
P3181
P356
10.1186/1472-6793-9-23
P407
P50
P577
2009-01-01T00:00:00Z
P5875
P6179
1034639250